From beat writer Richard Durrett of ESPN Dallas:
Many of the same teams that have had strong interest in Chicago Cubs right-hander Matt Garza were on hand to watch his outing on Saturday night at Wrigley Field.
The Texas Rangers and Toronto Blue Jays remain the front-runners for a trade with Chicago, according to industry sources. The Boston Red Sox, Cleveland Indians and San Francisco Giants have also expressed strong interest in the pitcher.
Garza was not great in that start, allowing two earned runs on 10 hits and two walks over 6 2/3 innings against the rival Cardinals. But he still has a shiny 3.17 ERA and 1.14 WHIP in 71 total innings this season and he’s probably the best available starting pitcher on the trade market (unless the Phillies suddenly decide to shop ace left-hander Cliff Lee).
Garza, 29, is making $10.25 million this season in his final year of salary arbitration. Phil Rogers of the Chicago Tribune hears that he will be traded before his next turn in the Cubs’ starting rotation.
Blue Jays right-hander Marcus Stroman might be headed to the disabled list soon, manager John Gibbons told reporters following Friday’s rain-shortened loss to the Yankees. The righty lasted just four innings on the mound before calling it a night, and gave up five runs, six hits and two walks in a performance that Gibbons claimed was at least partially affected by recurring blister issues on his right middle finger. Now, it looks like he might be removed from the rotation for some much-needed rest and rehabilitation; if so, it’ll be his second such stint this year.
Stroman, 27, has struggled to return the kind of winning record and sub-4.00 ERA that characterized his previous seasons with the club, mostly due to the combined seven weeks he missed with blisters on his throwing hand and chronic fatigue in his right shoulder. In a recent start against the Rays, things got even more gruesome when his blister appeared to start bleeding in the middle of his outing and MLB.com’s Gregor Chisholm notes that the wound has constantly interfered with the right-hander’s pitch selection and delivery. When healthy, Stroman has managed a 4-8 record through 18 starts in 2018 with a career-worst 5.27 ERA, 3.2 BB/9 and 6.8 SO/9 in 100 2/3 innings. This will be the first year since 2015 in which he has not logged at least 200 innings in a single season.
While Stroman may not need an extended stay on the DL before he returns to the mound, it’s not clear what kind of timetable the Blue Jays expect for his recovery. He’s been the second-most valuable starter (behind the now-traded J.A. Happ) in a rotation that currently ranks 17th in the majors with a combined 4.90 ERA and 6.8 fWAR.